Mercer Global Advisors’s BlackRock Health Sciences Trust BME Stock Holding History

Mercer Global Advisors’s Portfolio BME Stock Details BME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$65.1K	Buy	+1,516	New	+$60.2K	﹤0.01%	4138

Other funds holding BME

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

NRW

Nova R Wealth Overland Park, Kansas $343M AUM 17.7% 1-Year Est. Return

KIM

Karpus Investment Management Pittsford, New York $3.48B AUM 10.49% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Mercer Global Advisors's BME Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in BlackRock Health Sciences Trust (BME) in Q2 2026: 1,516 shares worth $65.1K. The stake represents ﹤0.01% of the portfolio and ranks #4138 among its holdings.

78 funds tracked by Wall St. Rank hold BME as of Q2 2026.

Mercer Global Advisors held 1,516 shares of BlackRock Health Sciences Trust worth $65.1K as of Q2 2026.
BlackRock Health Sciences Trust was a new Mercer Global Advisors position in Q2 2026.
BlackRock Health Sciences Trust made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #4138 holding.
78 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.